Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Sep 3, 2025 · 10-K · 977 days after period end · 0001641172-25-026446
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $25.99K | $15.17K | $10.89K |
| Net Income | $3.23M | $2.13M | -$2.03M | -$4.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Sep 3, 2025 · 977 d after period end
